Meda Agrees to Buy Three Drugs From J&J for $110.5 Million

Meda AB (MEDAA) agreed to buy three over- the-counter drugs from a unit of Johnson & JOhnson (JNJ) for 82 million euros ($110.5 million).

The drugs have combined annual sales of 210 million kronor ($31 million), Solna, Sweden-based Meda said in a statement today.

To contact the editor responsible for this story: Phil Serafino at pserafino@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.